HLA-Dr-expressing CD8bright cells are only temporarily present in the circulation during subcutaneous recombinant interleukin-2 therapy in renal cell carcinoma patients
暂无分享,去创建一个
N. Mulder | J. Buter | T. The | D. Sleijfer | E. Vries | L. Leij | R. Janssen | A. A. Heijn | E. Straatsma